Crossref
Caffeine-Loaded Mesoporous Silica Nanoparticles as a Dual-Pathway Therapeutic Strategy in Benzene-Induced Acute Myeloid Leukemia
Pharmaceutical Sciences and Drug Design · 2026 · 6 (2) · 87-105
DOI: 10.51847/y41ib4ufaf ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences and Drug Design, 2026. Verfasst von James Walker und 1 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Walker, J., & Harris, O. (2026). Caffeine-Loaded Mesoporous Silica Nanoparticles as a Dual-Pathway Therapeutic Strategy in Benzene-Induced Acute Myeloid Leukemia. Pharmaceutical Sciences and Drug Design, 6(2), 87-105. https://doi.org/10.51847/y41ib4ufaf
Vancouver
Walker J, Harris O. Caffeine-Loaded Mesoporous Silica Nanoparticles as a Dual-Pathway Therapeutic Strategy in Benzene-Induced Acute Myeloid Leukemia. Pharmaceutical Sciences and Drug Design. 2026;6(2):87-105. doi:10.51847/y41ib4ufaf
BibTeX
@article{Walker2026,
author = {Walker, James and Harris, Olivia},
title = {Caffeine-Loaded Mesoporous Silica Nanoparticles as a Dual-Pathway Therapeutic Strategy in Benzene-Induced Acute Myeloid Leukemia},
journal = {Pharmaceutical Sciences and Drug Design},
year = {2026},
volume = {6},
number = {2},
pages = {87--105},
doi = {10.51847/y41ib4ufaf}
}
EUVIMED